Helix BioPharma Corp. Opens the Market
26 Mayo 2016 - 9:59AM
PR Newswire (Canada)
TORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma
Corp. (HBP), joined Richard Rohan,
VP, Corporate Sales, TMX Equity Transfer & Trust Company, to
open the market to celebrate 20 years listed on Toronto Stock
Exchange. Helix BioPharma Corp. is a biopharmaceutical company
specializing in the development and commercialization of medicines
in the areas of cancer prevention and treatment. Helix BioPharma
Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.
SOURCE TMX Group Limited
Copyright 2016 Canada NewsWire
Helix BioPharma (TSX:HBP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Helix BioPharma (TSX:HBP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024